Massimo Campieri

16.9k total citations · 4 hit papers
227 papers, 12.3k citations indexed

About

Massimo Campieri is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Massimo Campieri has authored 227 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Genetics, 104 papers in Epidemiology and 73 papers in Surgery. Recurrent topics in Massimo Campieri's work include Inflammatory Bowel Disease (142 papers), Microscopic Colitis (96 papers) and Helicobacter pylori-related gastroenterology studies (28 papers). Massimo Campieri is often cited by papers focused on Inflammatory Bowel Disease (142 papers), Microscopic Colitis (96 papers) and Helicobacter pylori-related gastroenterology studies (28 papers). Massimo Campieri collaborates with scholars based in Italy, United Kingdom and United States. Massimo Campieri's co-authors include Paolo Gionchetti, Fernando Rizzello, Gilberto Poggioli, Patrizia Brigidi, Mario Miglioli, Alessandro Venturi, Gabriele Bazzocchi, Andrea Belluzzi, C. Brignola and Beatrice Vitali and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Massimo Campieri

223 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

2000 1.1k citations Paolo Gionchetti, Fernando Rizzello et al. Gastroenterology profile →
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

2003 794 citations Paolo Gionchetti, Fernando Rizzello et al. Gastroenterology profile →
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

2005 552 citations Paolo Gionchetti, Massimo Campieri et al. profile →
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease

1996 546 citations Andrea Belluzzi, Massimo Campieri et al. profile →

Peers

Countries citing papers authored by Massimo Campieri

Since Specialization

Citations

This map shows the geographic impact of Massimo Campieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Campieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Campieri more than expected).

Fields of papers citing papers by Massimo Campieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Campieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Campieri. The network helps show where Massimo Campieri may publish in the future.

Co-authorship network of co-authors of Massimo Campieri

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Campieri. A scholar is included among the top collaborators of Massimo Campieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Campieri. Massimo Campieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 2015 ·BioPsychoSocial Medicine ·Alessandro Agostini, Massimo Campieri, A. Bertani, A. Scarcelli, (unknown), Carlo Calabrese, Fernando Rizzello, Paolo Gionchetti, Paolo Nichelli, Francesca Benuzzi	30
2	Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 2012 ·Journal of Gastroenterology and Hepatology Research ·(unknown), Paolo Gionchetti, Carlo Calabrese, R. Tambasco, (unknown), Giuseppina Liguori, (unknown), Massimo Campieri, Fernando Rizzello	4
3	Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn’s disease versus healthy controls 2012 ·Journal of Behavioral Medicine ·Alessandro Agostini, Nicola Filippini, Francesca Benuzzi, A. Bertani, A. Scarcelli, Chiara Leoni, (unknown), (unknown), R. Tambasco, Carlo Calabrese, Fernando Rizzello, Paolo Gionchetti, Mauro Ercolani, Paolo Nichelli, Massimo Campieri	51
4	Potential role of the cannabinoid receptor CB₁ in the pathogenesis of erosive and non‐erosive gastro‐oesophageal reflux disease 2010 ·Alimentary Pharmacology & Therapeutics ·Carlo Calabrese, Enzo Spisni, Giuseppina Liguori, (unknown), Maria Chiara Valerii, Antonio Strillacci, Paolo Gionchetti, Uberto Pagotto, Massimo Campieri, Fernando Rizzello	8
5	Infliximab in the treatment of Crohn's disease 2007 ·Therapeutics and Clinical Risk Management ·Gilberto Poggioli, Silvio Laureti, Massimo Campieri, Filippo Pierangeli, Paolo Gionchetti, Federica Ugolini, Lorenzo Gentilini, (unknown), Fernando Rizzello, Maurizio Coscia	33
6	Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine 2005 ·Journal of Clinical Gastroenterology ·Paolo Gionchetti, Agesilao D’Arienzo, Fernando Rizzello, Francesco Manguso, (unknown), (unknown), Daniela Valpiani, Gaetano Iaquinto, Vito Annese, A. Balzano, Guido Varoli, Massimo Campieri	45
7	DNA derived from probiotic bacteria modulates human dendritic cell phenotype and function 2004 ·Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) ·(unknown), Ailsa Hart, MA Kamm, (unknown), (unknown), Patrizia Brigidi, Beatrice Vitali, Fernando Rizzello, Paolo Gionchetti, Massimo Campieri	1
8	Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial breakdown → 2003 ·Gastroenterology ·Paolo Gionchetti, Fernando Rizzello, Ulf Helwig, Alessandro Venturi, Karen M. Lammers, Patrizia Brigidi, Beatrice Vitali, Gilberto Poggioli, Mario Miglioli, Massimo Campieri	794
9	Bacteria as the cause of ulcerative colitis 2001 ·Gut ·Massimo Campieri, (unknown)	166
10	Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study 2001 ·Advances in Therapy ·Fernando Rizzello, Paolo Gionchetti, R Galeazzi, Giuseppe Novelli, D. Valpiani, A. D’Arienzo, Francesco Manguso, (unknown), Guido Varoli, Massimo Campieri	32
11	Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 1998 ·Diseases of the Colon & Rectum ·Paolo Gionchetti, Fernando Rizzello, A. Venturi, M. Ferretti, C. Brignola, M. Miglioli, Massimo Campieri	109
12	Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. 1997 ·Gut ·Paolo Gionchetti, Maurizio Vecchi, Fernando Rizzello, M. Ferretti, Carmen Calabresi, A. Venturi, Mauro Bianchi, C. Brignola, Renato Alberto Sinico, Roberto de Franchis, M. Miglioli, Massimo Campieri	16
13	Oral budesonide is as effective as oral prednisolone in active Crohn’s disease 1997 ·Gut ·Massimo Campieri, Alexander C. Ferguson, W F Doe, Tore Persson, L.-G. Nilsson, (unknown)	259
14	What is the best initial treatment and maintenance therapy for distal ulcerative colitis? 1996 ·Inflammatory Bowel Diseases ·Massimo Campieri	1
15	Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 1994 ·Alimentary Pharmacology & Therapeutics ·Andrea Belluzzi, C. Brignola, Massimo Campieri, Paolo Gionchetti, Fernando Rizzello, Stefano Boschi, (unknown), M. Miglioli, L. Barbara	8
16	Bronchopulmonary Involvement in Ulcerative Colitis 1990 ·Journal of Clinical Gastroenterology ·Paolo Gionchetti, M Schiavina, Massimo Campieri, A Fabiani, (unknown), Andrea Belluzzi, C. Brignola, Primiano Iannone, M. Miglioli, L. Barbara	16
17	Topical treatment with 5-ASA supositories in distal ulcerative colitis. A randomized double blind placebo controlled study with Asacol suppositories. An Italian co-operative study group 1989 ·Massimo Campieri, Giuseppe Brunetti, M. Miglioli, Barbara Leggett, Antonio Russo, Giuseppe Aprile, G. Bianchi Porro, Sandro Ardizzone, R. de Franchis, Giuseppe Grandinetti, Maurizio Vecchi, T Ranzi, Mauro Campanini, (unknown), Gabriele Riegler, G. Mazzacca, A. D’Arienzo, R. Caprilli, Giuseppe Frieri	1
18	The Possible Utility of Steroids in the Prevention of Relapses of Crohnʼs Disease in Remission 1988 ·Journal of Clinical Gastroenterology ·C. Brignola, Massimo Campieri, Patrizia Farruggia, A. Tragnone, Stefano Pasquali, Primiano Iannone, Giorgio Assuero Lanfranchi, Barbara Leggett	32
19	Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. 1985 ·Gut ·Massimo Campieri, Giorgio Assuero Lanfranchi, Silvia Boschi, C. Brignola, Gabriele Bazzocchi, Paolo Gionchetti, Manuela Minguzzi, Andrea Belluzzi, G Labò	54
20	Different patterns of intestinal transit time and anorectal motility in painful and painless chronic constipation. 1984 ·Gut ·Giorgio Assuero Lanfranchi, Gabriele Bazzocchi, C. Brignola, Massimo Campieri, G Labò	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact